See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Francis
Anzac Day
Artificial Intelligence
Social Media
Terrorist Attack
Newspaper Front Pages
Donald Trump
NFL
Tariffs
Vatican
IMF
Natural Disasters
Published • loading... • Updated

Augurex Secures Health Canada Approval for SPINEstat™, a First-in-Class Diagnostic Blood Test for Axial Spondyloarthritis - Life Sciences British Columbia

Summary by lifesciencesbc.ca
Augurex announced Health Canada has approved SPINEstat™, a diagnostic blood test for axial spondyloarthritis, as a Class II medical device.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
lifesciencesbc.califesciencesbc.ca

Augurex Secures Health Canada Approval for SPINEstat™, a First-in-Class Diagnostic Blood Test for Axial Spondyloarthritis - Life Sciences British Columbia

Augurex announced Health Canada has approved SPINEstat™, a diagnostic blood test for axial spondyloarthritis, as a Class II medical device.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

lifesciencesbc.ca broke the news in on Wednesday, April 16, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Vancouver, British Columbia

Vancouver, British Columbia

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal